跳至主要内容
临床试验/NCT06381063
NCT06381063招募中3 期

Effect of Non-steroidal Anti-inflammatory Drugs in Pain Management After Cardiac Surgery

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 238 人开始时间: 2024年3月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
招募中
入组人数
238
试验地点
1
主要终点
NSAIDs reduce postoperative at rest at 24 hours from the end of surgery

研究概览

简要总结

Non-steroidal anti-inflammatory drugs (NSAID) are part the multimodal strategy in pain management after surgery. However, major concerns are raised in cardiac surgery given the potential side effects of NSAID with more bleeding and acute kidney injury. The investigators hypothesized that NSAID are safe in the early postoperative course after cardiac surgery with respect to contraindication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • scheduled for cardiac surgery (aortic valve replacement, coronary artery bypass graft, mitral valve repair or replacement, intracardiac tumor, aortic root repair)
  • under cardiopulmonary bypass
  • Affiliation to the French national healthcare system
  • Written consent obtained

排除标准

  • weight<50 kg
  • chronic use of NSAID
  • mini-invasive surgery
  • NSAID contraindication
  • NSAID allergy
  • Nefopam contraindication
  • Paracetamol contraindication
  • Tramadol contraindication
  • Urgent surgery
  • Endocarditis
  • Immunosuppressive drug
  • HIV infection with CD4<200 mm3
  • Organ transplantation
  • Stage 4 or 5 chronic kidney disease
  • Gastro duodenal ulcer
  • Pregnancy
  • Depression
  • Auto immune disease

研究组 & 干预措施

Ketoprofen

Experimental

Ketoprofen 100 mg twice a day, during 48 after surgery, intravenous administration

干预措施: pain management (Drug)

Ketoprofen

Experimental

Ketoprofen 100 mg twice a day, during 48 after surgery, intravenous administration

干预措施: ketoprofen (Drug)

Placebo

Placebo Comparator

Placebo twice a day, during 48 h after surgery, intravenous administration

干预措施: pain management (Drug)

Placebo

Placebo Comparator

Placebo twice a day, during 48 h after surgery, intravenous administration

干预措施: PLacebo (Drug)

结局指标

主要结局

NSAIDs reduce postoperative at rest at 24 hours from the end of surgery

时间窗: at 24 hours

Pain intensity will be assessed at rest at 24 hours from the end surgery using the numerous rating scale (NRS) graded from 1 (no pain) to 10 (high pain intensity)

reduction in pain intensity during chest physiotherapy at 24 hours from the end of surgery

时间窗: at 24 hours

Pain intensity will be assessed using the NRS at 24 hours from the end of surgery during chest physiotherapy

次要结局

  • Change in pain trajectory during the first 7 days after cardiac surgery(7 days)
  • Change in cumulative opioid within 48 hours after surgery(48 hours)
  • Change in pulmonary postoperative complications within 7 days after surgery(7 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Non-steroidal Anti-inflammatory in Cardiac Surgery | 临床试验